Biotechnology | CDC | Disease
The CDC established the National Occupational Research Agenda (NORA)
In 1996, the U.S. Centers for Disease Control and Prevention (CDC) established the National Occupational Research Agenda (NORA). NORA…
University of Maryland cancer programs moved to a private facility and renamed the University of Maryland Cancer Center
In 1996, the University of Maryland cancer programs moved to a private facility and renamed the University of…
Biotechnology | Diagnostics | Disease | NIH | Oncology | Therapeutics
The Sidney Kimmel Cancer Center received NCI designation
In 1996, the Sidney Kimmel Cancer Center (SKCC) at Johns Hopkins University received National Cancer Institutes (NCI). The…
The first genetically engineered mouse model showing amyloid plaques was developed at the University of Minnesota
In 1996, the first genetically engineered mouse model showing amyloid plaques and dysfunctional learning and memory found in…
Brenda Gallie identified the cause of drug-resistant childhood cancer of the retina
In 1996, Dr. Brenda Gallie identified the cause of drug-resistant childhood cancer of the retina, leading to an…
The Sioux Valley Health System (Sanford Health) was founded
In 1996, The Sioux Valley Health System, now known as Sanford Health, was founded. In 2007, the Sioux…
Biotechnology | Disease | FDA | Therapeutics
Genentech drug Nutropin AQ ((somatropin) injection for subcutaneous use) was approved
On Dec. 29, 1995, the Genentech drug Nutropin AQ ((somatropin) injection for subcutaneous use) was approved by the…
Biotechnology | Disease | FDA | Oncology | Therapeutics
The FDA approved tretinoin, a differentiating agent related to vitamin A, for use in the treatment of acute promyelocytic leukemia
On Dec. 9, 1995, the U.S. Food and Drug Administration (FDA) approved tretinoin, a differentiating agent related to…
Richard D Klausner became the eleventh director of the National Cancer Institute, serving until 2001
On Aug. 1, 1985, Richard D. Klausner became the eleventh director of the National Cancer Institute, serving until…
The Barbara Ann Karmanos Cancer Institute was officially named
On Jul. 30, 1995, Peter Karmanos generously gave a large donation to the cancer research, patient care and…
President Bill Clinton proclaimed the first full week of April as National Public Health Week
In 1995, President Bill Clinton proclaimed the first full week of April as National Public Health Week (NPHW)….
Biotechnology | Diagnostics | Disease | NIH | Oncology
Information in NCI’s Physician Data Query (PDQ) database became available on the World Wide Web via the NCI Web site CancerNet
In 1995, Information in National Cancer Institute’s (NCI) Physician Data Query (PDQ) database became available on the World…
Gene therapy, immune-system modulation and recombinantly produced antibodies entered the clinic in the war against cancer
In 1995, Gene therapy, immune-system modulation and recombinantly produced antibodies enter the clinic in the war against cancer….
Scientists cloned the tumor suppressor genes BRCA1 and BRCA2
In 1995, scientists cloned the tumor suppressor genes BRCA1 and BRCA2, inherited genetic mutations that can predict an…
The first department of bioengineering in the U.S. was established at UC San Diego
In 1995, the first department of bioengineering in the U.S. was established at the University of California, San…
The National Sarcoidosis Society was established in Chicago
In 1995, the National Sarcoidosis Society was founded because of a lack of educational awareness information on this…
Triple-organ transplant was performed for the first time in the U.S.
In 1995, Brigham and Women’s surgeons performed the first triple-organ transplant in the U.S., removing three organs from…
Feinstein Institute for Medical Research was founded
In 1995, The Feinstein Institute for Medical Research was founded. The Institute was the research branch of the…
Biotechnology | Cloning | Diagnostics | Disease | Genomics | Oncology | Therapeutics | Women's Health
BRCA1 breast cancer-associated gene was identified by positional cloning methods
On Oct. 7, 1994, a strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility to breast and…
The fourth edition of the Diagnostic and Statistical Manual of Mental Disorders listed four subcategories within autistic disorder
In 1994, the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders listed four subcategories within…
The University of Iowa National Laboratory for the Study of Rural Telemedicine was established
In 1994, the National Laboratory for the Study of Rural Telemedicine was established at the University of Iowa…
The Stowers Institute for Medical Research was founded
In 1994, the Stowers Institute for Medical Research was founded by Jim and Virginia Stowers with a $500…
National Center for Genome Resources was founded
In 1994, National Center for Genome Resources (NCGR) founded with support from Senator Pete Domenici as an independent…
Diagnostics | Disease | NIH | Oncology | Therapeutics | Women's Health
Albert Einstein College becomes the only New York City medical school selected by the NIH to participate in the Women’s Health Initiative
In 1994, Albert Einstein College of Medicine becomes the only New York City medical school selected by the…
The Medical Research Foundation became an affiliate committee of the OHSU Foundation
In 1994, the Medical Research Foundation (MRF) became an affiliate committee of the Oregon Health & Science University…
Biotechnology | Diagnostics | Disease | FDA | Neurology | Ophthalmogy
Omeros Corp was founded
In 1994, Omeros Corp. was founded in Seattle as a biopharmaceutical company committed to discovering, developing and commercializing…
Biotechnology | Disease | FDA | Medicine
Genentech drug Pulmozyme (dornase alfa) was approved by the FDA
On Dec. 30, 1993, the Genentech drug Pulmozyme (dornase alfa) was approved by the U.S. Food and Drug…
Dr. Judes Poirier discovered that apolipoprotein E is a genetic risk factor for Alzheimer’s disease
On Sept. 18, 1993, Dr. Judes Poirier discovered that apolipoprotein E was a genetic risk factor for Alzheimer’s…
Biotechnology | Disease | FDA | Therapeutics
FDA approved Betaseron, the first of several biotech products that have had a major impact on multiple sclerosis treatment
On Jul. 23, 1993, the U.S. Food and Drug Administration (FDA) approved Bayer’s Betaseron, the first of several…
Chiron’s Betaseron was approved as the first treatment for multiple sclerosis in 20 years
On Jul. 23, 1993, Chiron and Berlex Laboratories announced that the U.S. Food and Drug Administration (FDA) had…